UnitedHealth Group Incorporated(UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Latest News & Analysis
UnitedHealth (UNH): Medicare Advantage Boost vs. DOJ Investigation
UNH is navigating market opportunities and regulatory challenges. A Medicare Advantage payment hike offers a revenue boost, but a DOJ investigation looms.
UnitedHealth (UNH): Navigating DOJ Probe, DEI Shifts, and Utilization Pressures
UnitedHealth Group (UNH) faces DOJ scrutiny, DEI policy shifts, rising healthcare utilization, and regulatory changes. Analysis of challenges, financial impact, and market position.
UnitedHealth (UNH): DOJ Probe, Earnings, and Future of Healthcare
UnitedHealth Group (UNH) faces regulatory scrutiny and macroeconomic pressures while embracing innovation. Upcoming earnings, DOJ investigation, and Optum Rx's initiatives are key.
UnitedHealth Group: DOJ Probe, Optum Rx, and Security Costs
UnitedHealth faces DOJ scrutiny over billing, Optum Rx simplifies prescriptions, and executive security spending rises. Stock shows mixed performance amidst these developments.
UnitedHealth (UNH) Under DOJ Scrutiny: Market Impact Analysis
UnitedHealth Group (UNH) faces a DOJ investigation, fiduciary duty scrutiny, and rising security costs, impacting its stock performance and investor confidence.
UnitedHealth (UNH) Under DOJ Investigation: Investor Impact
UnitedHealth Group (UNH) faces a DOJ investigation over billing practices, sparking investor concerns and a fiduciary duty probe. Analysis of potential impacts on UNH stock and financials.
UnitedHealth (UNH) Faces DOJ Probe: Investor Impact & Analysis
UnitedHealth Group (UNH) faces a DOJ probe into Medicare billing, sparking investor concerns. Analysis of UNH's market position, financial health, and competitive dynamics.
UnitedHealth (UNH) Intraday Update: Legal, Earnings & Strategy
Intraday update on UnitedHealth’s performance, legal rulings, and strategic growth initiatives. Data-driven analysis from verified sources.
UnitedHealth Group (UNH) Under DOJ Investigation: Market Analysis and Outlook
UnitedHealth Group (UNH) faces a DOJ probe into Medicare billing, sparking market volatility and investor concern. Our analysis dives deep into the allegations and outlook.
UnitedHealth Group (UNH) Under Scrutiny: DOJ Probe, Regulatory Challenges, and Market Impact
UnitedHealth Group (UNH) faces a DOJ probe, Senator Grassley's inquiry, and rising costs. Analysis of challenges and opportunities for investors.
UnitedHealth Group (UNH) Faces DOJ Probe: Market Impact & Analysis
UnitedHealth Group (UNH) faces a DOJ probe, Senator Grassley's inquiry, rising medical costs, and coverage changes, creating market uncertainty. Read our analysis.
UnitedHealth Group (UNH) Under Fire: DOJ Probe, Rising Costs, and Market Volatility
UnitedHealth Group (UNH) faces a DOJ probe, rising medical costs, and market volatility. This report analyzes the impact on UNH's stock and the healthcare industry.
UnitedHealth Group (UNH) Under Scrutiny: DOJ Investigation and Market Impact
UnitedHealth Group (UNH) faces a DOJ probe, sparking market volatility. This analysis covers allegations, financial impacts, competition, and the long-term outlook for investors.
UnitedHealth Group Under Scrutiny: DOJ Investigation and Market Volatility
UnitedHealth Group (UNH) faces a DOJ probe into Medicare billing, causing market volatility. Despite this, some analysts see it as oversold. Key takeaways inside.
UnitedHealth Group Faces Medicare Billing Investigation
UnitedHealth Group faces a DOJ probe into Medicare billing practices amid cyberattacks and executive losses, spurring significant market volatility.
UnitedHealth Group Restructuring and Market Impact: Workforce Reduction and Future Outlook
An in-depth analysis of UnitedHealth Group's recent workforce restructuring, regulatory challenges, and strategic shifts affecting market performance.
UnitedHealth Group: Market Impact, Regulatory Challenges, and Future Outlook
A comprehensive intraday analysis of UnitedHealth Group’s market performance, strategic initiatives, and regulatory challenges.
UNH Navigates Regulatory Headwinds & Market Volatility
An in‐depth analysis of UNH’s stock performance, regulatory setbacks, dividend trends, and growth strategies amid market volatility.